Significantly More Smokers With Mild-To-Moderate COPD Quit Smoking Using CHANTIX/CHAMPIX(R) (Varenicline) Compared With Placebo
November 6, 2009 by admin
Filed under Best Way To Quit Smoking, Quit Smoking Information
New study results showed that 42.3 percent of smokers with mild-to-moderate chronic obstreperous pulmonary disease (COPD) who took CHANTIX/CHAMPIX® (varenicline) were able to quit smoking and remain temperate during the last four weeks of treatment (weeks 9-12) compared with 8.8 percent of those given placebo (p
Related posts:
- Is Chantix FDA Approved? Yes! Chantix was approved by FDA May 11, 2006....
- Study Examines Smoking Practices And Attitudes Among Anesthesiologists In China, The Country With The Highest Population Of Smokers The statistics are frightening: one-third of the world’s smokers...
- Quit Smoking Pill… Chantix (varenicline) Or Zyban (bupropion) ? Anyone have any experience with taking Chantix (Varenicline) or Zyban...
- U.S. Adult Smoking Rates Remain Stalled Despite progress in some areas, smoking rates among U.S. adults...
- Around One In Five Pregnant Smokers Go Undetected Each Year Self-reported smoking during pregnancy underestimates the right number of pregnant...
